Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
NHS England Announces New Innovative Medicines Fund to Fast-track Promising New Drugs
NHS patients are set to benefit from early access to potentially life-saving new medicines, including cutting-edge gene therapies, […]
Researchers Behind Lifesaving Astra-Zeneca Jab Named Winners Of NHS Gong
Research teams at Oxford University who joined forces to fight coronavirus by developing a covid […]
NHS Chief Hails ‘Unprecedented’ Honour For Staff
Sir Simon Stevens today hailed the “skill and compassion and the fortitude” of health service […]
NHS Launches Online Service to Find Nearest Walk-in Jab Site
The NHS COVID-19 Vaccination programme, the biggest in health service history, today launched a new […]
my mhealth and University of Southampton announced as Round 2 Winner of The Artificial Intelligence in Health and Care Award
my mhealth Limited and the University of Southampton have been announced as a winner of […]
Over One Million Jabs Booked as NHS Vaccine Programme Opens to All Adults
More than one million jab appointments were booked since the NHS vaccination programme opened for […]
£36 Million Boost for AI Technologies to Revolutionise NHS Care
New technology will help detect cancers and provide mental health support Projects are part of […]
Half a Million COVID Jabs Booked in ‘Glastonbury Rush’ This Morning
The NHS saw a welcome surge in demand for vaccines this morning as half a […]
NHS Treats First Patient with the ‘World’s Most Expensive Drug’
A five-month old baby has become the first patient to receive a potentially life-saving drug […]
60 Million Doses of Covid-19 Vaccine Administered in UK
Around 72% of UK adults have received a first dose of a COVID-19 vaccine, the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more